Fexofenadine Bluefish 180 mg Filmdragerad tablett

국가: 스웨덴

언어: 스웨덴어

출처: Läkemedelsverket (Medical Products Agency)

유효 성분:

fexofenadinhydroklorid

제공처:

Bluefish Pharmaceuticals AB

ATC 코드:

R06AX26

INN (International Name):

fexofenadine hydrochloride

복용량:

180 mg

약제 형태:

Filmdragerad tablett

구성:

fexofenadinhydroklorid 180 mg Aktiv substans

처방전 유형:

Receptbelagt

제품 요약:

Förpacknings: Blister, 7 tabletter; Blister, 10 tabletter; Blister, 15 tabletter; Blister, 20 tabletter; Blister, 30 tabletter; Blister, 50 tabletter; Blister, 100 tabletter; Blister, 200 (10 x 20) tabletter

승인 상태:

Godkänd

승인 날짜:

2017-09-25

환자 정보 전단

1
PACKAGE LEAFLET
2
PACKAGE LEAFLET: INFORMATION FOR THE USER
FEXOFENADINE BLUEFISH 180MG FILM-COATED TABLETS
Fexofenadine hydrochloride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist or
nurse. This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Fexofenadine Bluefish is and what it is used for
2.
What you need to know before you take Fexofenadine Bluefish
3.
How to take Fexofenadine Bluefish
4.
Possible side effects
5.
How to store Fexofenadine Bluefish
6.
Contents of the pack and other information
1.
WHAT FEXOFENADINE BLUEFISH IS AND WHAT IT IS USED FOR
Fexofenadine Bluefish contains fexofenadine hydrochloride, which is a
non-drowsy antihistamine.
Fexofenadine Bluefish 180 mg is used in adults and adolescents of 12
years and older to relieve the symptoms
that occur with long term allergic skin reactions (chronic idiopathic
urticaria) such as itching, swelling and
rashes.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE FEXOFENADINE BLUEFISH
DO NOT TAKE FEXOFENADINE BLUEFISH
-
if you are allergic to fexofenadine or any of the other ingredients of
this medicine (listed in section 6).
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking Fexofenadine Bluefish
if :
-
you have or ever had heart disease, since this kind of medicine may
lead to a fast or irregular heart beat
-
you are elderly
-
you have problems with your liver or kidneys.
If any of these apply to you, or if you are not sure, tell your doctor
before taking Fexofenadine Bluefish.
OTHER MEDICINES AND FEXOFENADINE BLUEFISH
Tell your doctor or pharmacist if you are taki

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Fexofenadine Bluefish 180 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 180 mg fexofenadine hydrochloride, which is
equivalent to 168 mg fexofenadine.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet
Yellow, 17 mm x 8 mm capsule-shaped, biconvex, film-coated tablet with
a score line on one side.
The score line is only to facilitate breaking for ease of swallowing
and not to divide into equal doses.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Fexofenadine Bluefish 180 mg is indicated in adults and children 12
years and older for the relief of
symptoms associated with chronic idiopathic urticaria.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults _
The recommended dose of fexofenadine hydrochloride for adults is 180
mg once daily taken before a meal.
Fexofenadine is a pharmacologically active metabolite of terfenadine.
_Paediatric population _
•
Children aged 12 years and over
The recommended dose of fexofenadine hydrochloride for children aged
12 years and over is 180 mg once
daily taken before a meal.
•
Children under 12 years of age
The efficacy and safety of fexofenadine hydrochloride 180 mg has not
been studied in children under 12
years of age.
_Special populations _
Studies in special risk groups (elderly, renally or hepatically
impaired patients) indicate that it is not
necessary to adjust the dose of fexofenadine hydrochloride in these
patients.
Method of administration
Oral use
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
There is limited data in the elderly and renally or hepatically
impaired patients. Fexofenadine hydrochloride
should be administered with care in these special groups(see section
4.2).
Patients with a history of or ongoing cardiovascular disease should be
warned that, antihistamines as a
medicine class, h